Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease

Emilio Nardi1, Alessandro Palermo, Giuseppe Mulè

  • 1Dipartimento di Medicina Interna, Cattedra di Medicina Interna and Hypertension Excellence Centre of the European Society of Hypertension, Università degli Studi di Palermo, Palermo, Italy. emilionardi@virgilio.it

Insights

Left ventricular hypertrophy (LVH) is common in chronic kidney disease (CKD) patients, often inappropriate and linked to worsening renal function. This study compared LVH in hypertensive patients with CKD versus those with normal kidney function.

Area of Science:

  • Cardiology
  • Nephrology
  • Clinical Hypertension

Background:

  • Hypertension is a major risk factor for cardiovascular complications.
  • Chronic kidney disease (CKD) is associated with increased cardiovascular morbidity and mortality.
  • Left ventricular hypertrophy (LVH) is a common cardiac adaptation in hypertensive patients.

Purpose of the Study:

  • To determine the prevalence of LVH and left ventricular geometry in hypertensive patients with stages 2-5 CKD.
  • To compare LVH and geometry between hypertensive patients with CKD and those with normal renal function.

Main Methods:

  • Echocardiographic examination was performed on 293 hypertensive patients with CKD (stage 2-5) and 289 hypertensive patients with normal renal function.
  • Exclusion criteria included stage 1 CKD, dialysis, and pre-existing cardiovascular diseases.

Main Results:

  • LVH prevalence was significantly higher in CKD patients (47.1%) compared to controls (31.14%).
  • CKD patients showed increased left ventricular diameters, thicknesses, and mass, particularly in advanced stages.
  • Inappropriate left ventricular mass was more prevalent in CKD patients (52.6%) vs. controls (30.5%).
  • Renal function independently associated with left ventricular mass; diastolic function was impaired in CKD patients.

Conclusions:

  • LVH is highly prevalent in hypertensive patients with CKD.
  • LVH in CKD patients is often inappropriate, with increased wall thickness and diameter.
  • Worsening renal function correlates with increased left ventricular mass and impaired diastolic function.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...